Covid-19. Covid-19
Conditions
Interventions
Intervention 1: Control group: Standard Protocol Drugs + placebo (in terms of appearance and color similar to vitamin C) every 12 hours for 5 days. Intervention 2: Intervention group: Standard Protoc
Sponsors
Abadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: COVID-19 patients that have positive PCR test of nasopharyngeal sample or have positive CT Scan
Exclusion criteria
Exclusion criteria: Pregnant or breast feeding women Patients with kidney stone Patients with diabetes Patients under 18 years of age Chronic renal failure Patient with urinary tract infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery within 10 days of starting the drug. Recovery means: (no fever, no shortness of breath, no cough or improved, no fatigue or improved) for 24 hours. Timepoint: Daily. Method of measurement: Clinical observation and examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| The change of inflammatory markers. Timepoint: Admission and discharge day. Method of measurement: C-reactive protein, neutrophil-lymphocyte ratio.;Rate of survival. Timepoint: Daily. Method of measurement: census report.;Days admitted in hospital. Timepoint: Daily since hospitalization time. Method of measurement: Based on patient's file.;Days intubated/under ventilator. Timepoint: Daily. Method of measurement: observation.;Days admitted in ICU. Timepoint: Daily. Method of measurement: Based on patient's file.;Time to clinical improvement (TTIC) of NEWS2 (National Early Warning Score 2) of 0 maintained for 24 hours. Timepoint: Day of admission, fifth and discharge. Method of measurement: NEWS2 (National Early Warning Score 2) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Mobarak
Abadan University of Medical Sciences
Outcome results
None listed